Sangamo Therapeutics
SGMO
SGMO
156 hedge funds and large institutions have $560M invested in Sangamo Therapeutics in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 47 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $825M → $560M (-$265M)
42% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 36
Holders
156
Holding in Top 10
1
Calls
$142M
Puts
$4.63M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$9.8M | |
| 3 | +$3.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.46M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$2.63M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$14.6M | |
| 3 | -$8.78M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$6.7M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$6.57M |